SE467053B - Katekolderivat till anvaendning som terapeutikum, foerfarande foer framstaellning daerav samt terapeutiska kompositioner innehaallande dem - Google Patents

Katekolderivat till anvaendning som terapeutikum, foerfarande foer framstaellning daerav samt terapeutiska kompositioner innehaallande dem

Info

Publication number
SE467053B
SE467053B SE8603793A SE8603793A SE467053B SE 467053 B SE467053 B SE 467053B SE 8603793 A SE8603793 A SE 8603793A SE 8603793 A SE8603793 A SE 8603793A SE 467053 B SE467053 B SE 467053B
Authority
SE
Sweden
Prior art keywords
carbon atoms
group
groups
mono
alkyl group
Prior art date
Application number
SE8603793A
Other languages
English (en)
Swedish (sv)
Other versions
SE8603793L (sv
SE8603793D0 (sv
Inventor
M Follet
M Bonato
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE8603793D0 publication Critical patent/SE8603793D0/xx
Publication of SE8603793L publication Critical patent/SE8603793L/xx
Publication of SE467053B publication Critical patent/SE467053B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Steroid Compounds (AREA)
SE8603793A 1985-09-26 1986-09-10 Katekolderivat till anvaendning som terapeutikum, foerfarande foer framstaellning daerav samt terapeutiska kompositioner innehaallande dem SE467053B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858523776A GB8523776D0 (en) 1985-09-26 1985-09-26 Catechol derivatives

Publications (3)

Publication Number Publication Date
SE8603793D0 SE8603793D0 (sv) 1986-09-10
SE8603793L SE8603793L (sv) 1987-03-27
SE467053B true SE467053B (sv) 1992-05-18

Family

ID=10585770

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8603793A SE467053B (sv) 1985-09-26 1986-09-10 Katekolderivat till anvaendning som terapeutikum, foerfarande foer framstaellning daerav samt terapeutiska kompositioner innehaallande dem
SE8603792A SE464522B (sv) 1985-09-26 1986-09-10 Nya bicykliska katekolderivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8603792A SE464522B (sv) 1985-09-26 1986-09-10 Nya bicykliska katekolderivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem

Country Status (28)

Country Link
US (2) US4699919A (de)
JP (2) JPS6284055A (de)
AR (2) AR242559A1 (de)
AT (2) AT402070B (de)
BE (2) BE905433A (de)
CA (2) CA1278299C (de)
CH (2) CH668421A5 (de)
DE (2) DE3632841A1 (de)
DK (2) DK165115C (de)
DZ (2) DZ990A1 (de)
ES (2) ES2001705A6 (de)
FI (2) FI84480C (de)
FR (4) FR2587702B1 (de)
GB (3) GB8523776D0 (de)
HK (2) HK91289A (de)
IE (2) IE59478B1 (de)
IT (2) IT1235761B (de)
LU (2) LU86590A1 (de)
MA (2) MA20780A1 (de)
MY (2) MY103521A (de)
NL (2) NL189334C (de)
NO (2) NO170415C (de)
OA (2) OA08417A (de)
PT (2) PT83437B (de)
SE (2) SE467053B (de)
SG (1) SG65889G (de)
TN (2) TNSN86135A1 (de)
ZA (2) ZA866905B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927629A (en) * 1987-12-17 1990-05-22 Huntington Medical Research Institutes Relaxation of smooth vascular muscle
WO1999024038A1 (en) 1997-11-07 1999-05-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility
US20100075926A1 (en) * 2008-07-23 2010-03-25 Li-Huei Tsai Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
CA2842524C (en) 2011-07-22 2020-07-14 Massachusetts Institute Of Technology Activators of class i histone deacetylases (hdacs) and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2549118A (en) * 1949-10-05 1951-04-17 Us Rubber Co Vulcanized rubber and method of preserving same
CH301691A (de) * 1951-08-07 1954-09-15 Cilag Ag Verfahren zur Herstellung eines neuen aromatischen Thioäthers.
CH301687A (de) * 1951-08-07 1954-09-15 Cilag Ag Verfahren zur Herstellung eines neuen aromatischen Thioäthers.
CH301688A (de) * 1951-08-07 1954-09-15 Cilag Ag Verfahren zur Herstellung eines neuen aromatischen Thioäthers.
US3148997A (en) * 1963-01-04 1964-09-15 Dow Chemical Co Catechol compounds in improving clays and clay-containing materials
US3274257A (en) * 1963-06-17 1966-09-20 Dow Chemical Co Synthesis of (alkylthio) phenols
US3282979A (en) * 1963-06-17 1966-11-01 Dow Chemical Co Phenolic thioethers
GB1362782A (en) * 1970-08-26 1974-08-07 Fisons Ltd Tetrazole derivatives
US3751483A (en) * 1971-10-13 1973-08-07 Crown Zellerbach Corp Phenolic thioethers and process for preparing same
GB1428110A (en) * 1972-05-30 1976-03-17 Reckitt & Colmann Prod Ltd Pharmaceutical antihypertensive and vasodilator compositions
JPS506340A (de) * 1973-05-16 1975-01-23
DE2644591A1 (de) * 1976-10-02 1978-04-06 Bayer Ag Verfahren zur herstellung von arylsulfoniumsalzen
AU548253B2 (en) * 1981-05-11 1985-12-05 Pierre Fabre S.A. Benzoxepine derivatives and sulphur and nitrogen analogues thereof
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
JPS60260532A (ja) * 1984-06-07 1985-12-23 Yamanouchi Pharmaceut Co Ltd 新規カテコ−ル誘導体
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers

Also Published As

Publication number Publication date
AT396469B (de) 1993-09-27
GB8623075D0 (en) 1986-10-29
DE3632841A1 (de) 1987-04-02
IE862533L (en) 1987-03-26
FI87646B (fi) 1992-10-30
NO170415B (no) 1992-07-06
FI84480B (fi) 1991-08-30
CA1278299C (en) 1990-12-27
DK457386A (da) 1987-03-27
NL189410B (nl) 1992-11-02
DK165115C (da) 1993-03-01
SE8603793L (sv) 1987-03-27
FR2587703B1 (fr) 1988-11-04
SE8603792D0 (sv) 1986-09-10
NO863834D0 (no) 1986-09-25
NO165238B (no) 1990-10-08
BE905432A (fr) 1987-03-16
IE59478B1 (en) 1994-03-09
PT83436A (en) 1986-10-01
NL189410C (nl) 1993-04-01
GB2181431B (en) 1989-09-20
FR2587698A1 (fr) 1987-03-27
US4699919A (en) 1987-10-13
NO863835L (no) 1987-03-27
OA08416A (fr) 1988-06-30
ZA866906B (en) 1987-04-29
PT83437A (en) 1986-10-01
MY103521A (en) 1993-07-31
MY105863A (en) 1995-02-28
JPS6284080A (ja) 1987-04-17
MA20779A1 (fr) 1987-04-01
DK168334B1 (da) 1994-03-14
JPH0417956B2 (de) 1992-03-26
FR2587703A1 (fr) 1987-03-27
ES2001705A6 (es) 1988-06-01
US5013756A (en) 1991-05-07
AR241702A1 (es) 1992-11-30
IE59479B1 (en) 1994-03-09
FR2587699A1 (fr) 1987-03-27
TNSN86134A1 (fr) 1990-01-01
LU86590A1 (fr) 1987-01-22
FI84480C (fi) 1991-12-10
CH668261A5 (fr) 1988-12-15
ATA257386A (de) 1993-01-15
JPH0482129B2 (de) 1992-12-25
TNSN86135A1 (fr) 1990-01-01
MA20780A1 (fr) 1987-04-01
IE862532L (en) 1987-03-26
PT83437B (pt) 1988-07-29
NO165238C (no) 1991-01-16
FI863742A (fi) 1987-03-27
IT1235761B (it) 1992-09-28
NO170415C (no) 1992-10-14
FR2587702A1 (fr) 1987-03-27
SE464522B (sv) 1991-05-06
NO863835D0 (no) 1986-09-25
NL8602382A (nl) 1987-04-16
FI863742A0 (fi) 1986-09-16
AT402070B (de) 1997-01-27
FI863743A (fi) 1987-03-27
DK457486A (da) 1987-03-27
FI87646C (fi) 1993-02-10
CA1318686C (en) 1993-06-01
DE3632841C2 (de) 1992-06-11
FR2587702B1 (fr) 1988-11-04
GB8523776D0 (en) 1985-10-30
SG65889G (en) 1990-01-26
NL8602383A (nl) 1987-04-16
DK165115B (da) 1992-10-12
SE8603793D0 (sv) 1986-09-10
ZA866905B (en) 1987-04-29
LU86591A1 (fr) 1987-01-22
GB2181431A (en) 1987-04-23
PT83436B (pt) 1988-07-29
HK91289A (en) 1989-11-24
CH668421A5 (fr) 1988-12-30
HK46190A (en) 1990-06-22
AR242559A1 (es) 1993-04-30
FR2587698B1 (fr) 1989-04-28
NL189334C (nl) 1993-03-16
DK457486D0 (da) 1986-09-25
FI863743A0 (fi) 1986-09-16
GB8623074D0 (en) 1986-10-29
IT8621837A0 (it) 1986-09-26
SE8603792L (sv) 1987-03-27
IT1235760B (it) 1992-09-28
NO863834L (no) 1987-03-27
DE3632824C2 (de) 1992-04-30
IT8621836A0 (it) 1986-09-26
ATA257486A (de) 1996-06-15
OA08417A (fr) 1988-06-30
DZ991A1 (fr) 2004-09-13
DZ990A1 (fr) 2004-09-13
GB2189782A (en) 1987-11-04
DE3632824A1 (de) 1987-04-02
ES2001440A6 (es) 1988-05-16
BE905433A (fr) 1987-03-16
GB2189782B (en) 1989-04-12
JPS6284055A (ja) 1987-04-17
DK457386D0 (da) 1986-09-25
FR2587699B1 (fr) 1988-11-10

Similar Documents

Publication Publication Date Title
Piper et al. Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro.
US4857558A (en) Methods and compositions for inhibiting lipoxygenase
Piper et al. Leukotrienes
US5688821A (en) Unsaturated fatty acyl derivatives of 2-aminothiazoleacetic acid and their salts as inhibitors of phospholipase A2 derived from human sources
SE467053B (sv) Katekolderivat till anvaendning som terapeutikum, foerfarande foer framstaellning daerav samt terapeutiska kompositioner innehaallande dem
Samhoun et al. Actions and interactions of lipoxygenase and cyclo-oxygenase products in respiratory and vascular tissues
JPH0379337B2 (de)
Vane Anti-inflammatory drugs and the arachidonic acid cascade
US4659732A (en) Lipoxygenase inhibiting 1-arylalkyl-, 1-arylthio-, and 1-aryloxypyrazole-4,5-diones
US5496855A (en) Anti-inflammatory compounds
US4624964A (en) Aryl oxo-alkynoates as 5-lipoxygenase inhibitors
US5229421A (en) Methods and compositions for inhibiting lipoxygenase
HUPPERICH et al. Substrate and inhibitor specificity of 3-hydroxy-3-methylglutaryl-CoA reductase determined with substrate-analogue CoA-thioesters and CoA-thioethers
US4510323A (en) Cis-bicyclo[3.3.0]octane derivatives, medicaments containing them and processes for their preparation and use
McGuire et al. Metabolism of (5E)-6a-carboprostaglandin I2 by rhesus monkey lung 15-OH prostaglandin dehydrogenase
JPS60142936A (ja) 置換フエニル誘導体
JPH1149675A (ja) Ａｂ５３６６物質を含むアレルギー性疾患の予防、治療薬と酵素阻害剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8603793-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8603793-4

Format of ref document f/p: F